These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16081767)

  • 1. Effect of CD3/CD28 bead-activated T cells on leukemic B cells in chronic lymphocytic leukemia.
    Prieto A; Sanchez M; Perucha E; Alvarez-Mon M
    J Immunol; 2005 Aug; 175(4):2042-3. PubMed ID: 16081767
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia.
    Patten P; Devereux S; Buggins A; Bonyhadi M; Frohlich M; Berenson RJ
    J Immunol; 2005 Jun; 174(11):6562-3; author reply 6563. PubMed ID: 15905490
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
    Bonyhadi M; Frohlich M; Rasmussen A; Ferrand C; Grosmaire L; Robinet E; Leis J; Maziarz RT; Tiberghien P; Berenson RJ
    J Immunol; 2005 Feb; 174(4):2366-75. PubMed ID: 15699173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
    Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
    Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
    Johnson-Léger C; Christensen J; Klaus GG
    Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.
    Kalamasz D; Long SA; Taniguchi R; Buckner JH; Berenson RJ; Bonyhadi M
    J Immunother; 2004; 27(5):405-18. PubMed ID: 15314550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 enhances IL-13 production by T cells activated through CD3/CD28.
    Dumont FJ
    Int Arch Allergy Immunol; 1997 Nov; 114(3):300-1. PubMed ID: 9363914
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation.
    Klaus GG; Holman M; Johnson-Léger C; Christenson JR; Kehry MR
    Int Immunol; 1999 Jan; 11(1):71-9. PubMed ID: 10050675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo GH; June CH; Levine BL; Lum LG
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):473-9. PubMed ID: 10772300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
    Kusmartsev SA; Li Y; Chen SH
    J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
    Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
    Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
    Hombach A; Schlimper C; Sievers E; Frank S; Schild HH; Sauerbruch T; Schmidt-Wolf IG; Abken H
    Gut; 2006 Aug; 55(8):1156-64. PubMed ID: 16188919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel substrates for tumor immunotherapy.
    Shalaby WS; Yeh H; Woo E; Hendren S; Corbett JT; Gray H; June CH; Shalaby SW
    J Control Release; 2003 Aug; 91(1-2):209-24. PubMed ID: 12932653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv.
    Zhong K; Liu Z; Li H; Zhao S; Wang Y; Guo W; Zheng X; Yang H; Guo G; Zhou L; Xu J; Tong A
    Aging (Albany NY); 2020 Jun; 12(11):11061-11070. PubMed ID: 32526703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC.
    Hock BD; Macpherson SA; Fernyhough LJ; McKenzie JL
    Leuk Res; 2014 Oct; 38(10):1217-23. PubMed ID: 24976339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.
    Walsh PT; O'Connor R
    Eur J Immunol; 2000 Apr; 30(4):1010-8. PubMed ID: 10760788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic and eicosapentaenoic acids inhibit the CD28-lymphocyte activation pathway in vitro.
    Khalfoun B; Sibué D; Bardos P; Lebranchu Y
    Transplant Proc; 1998 Dec; 30(8):3978-9. PubMed ID: 9865267
    [No Abstract]   [Full Text] [Related]  

  • 20. Floating the molecular machinery for t-cell activation.
    Lencer WI
    Gastroenterology; 1999 Aug; 117(2):503-5. PubMed ID: 10419936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.